| Literature DB >> 32399474 |
Yuko Oyama1, Yoichi Iwafuchi1, Tetsuo Morioka2, Ichiei Narita3.
Abstract
Oliguric acute kidney injury (AKI) with minimal change nephrotic syndrome (MCNS) has long been recognized. Several mechanisms such as hypovolemia due to hypoalbuminemia and the nephrosarca hypothesis have been proposed. However, the precise mechanism by which MCNS causes AKI has not been fully elucidated. Herein, we describe an elderly patient with AKI caused by MCNS who fully recovered after aggressive volume withdrawal by hemodialysis and administration of a glucocorticoid. A 75-year-old woman presented with diarrhea and oliguria, and laboratory examination revealed nephrotic syndrome (NS) and severe azotemia. Fluid administration had no effect on renal dysfunction, and hemodialysis was initiated. Her renal function improved upon aggressive fluid removal through hemodialysis. Renal pathological findings revealed minimal change disease with faint mesangial deposits of IgA. After administration of methylprednisolone pulse therapy followed by oral prednisolone, she achieved complete remission from NS. The clinical course of this case supports the nephrosarca hypothesis regarding the mechanism of AKI caused by MCNS. Furthermore, appropriate fluid management and kidney biopsy are also important in elderly patients with AKI caused by NS.Entities:
Keywords: Acute kidney injury; Elderly patient; Kidney biopsy; Minimal change nephrotic syndrome; Nephrosarca hypothesis
Year: 2020 PMID: 32399474 PMCID: PMC7204776 DOI: 10.1159/000507426
Source DB: PubMed Journal: Case Rep Nephrol Dial
Laboratory data on admission
| Na | 120 | mEq/L | C3 | 151 (80–140) | mg/dL | ||||||
| WBC | 15,700 | /µL | K | 6.7 | mEq/L | C4 | 69.1 (11–34) | mg/dL | Specific gravity | 1.030 | |
| Neutro | 96.1 | % | Cl | 89 | mEq/L | CH50 | 62.0 (30–45) | IU/L | PH | 5.5 | |
| Lym | 2.1 | % | Ca | 7.3 | mg/dL | TSH | 2.64 | µIU/mL | Protein | (4+) | |
| Mono | 1.7 | % | IP | 16.8 | mg/dL | fT3 | 1.34 | Pg/mL | TP | 9.38 | g/gCr |
| Eosino | 0.0 | % | TP | 5.7 | g/dL | fT4 | 0.83 | ng/dL | Glucose | (−) | |
| Baso | 0.1 | % | Alb | 2.4 | g/dL | MPO–ANCA | (−) | Occult blood | (±) | ||
| Platelets | 35.0×104 | /µL | TC | 351 | mg/dL | PR3-ANCA | (−) | RBC | 5–9 | /HPF | |
| RBC | 455×104 | /µL | TG | 279 | mg/dL | Anti-GBM Ab | (−) | WBC | 5–9 | /HPF | |
| Hb | 14.3 | g/dL | LDL-C | 130 | mg/dL | ANA | (−) | Granular cast | 1–4 | /WF | |
| BS | 116 | mg/dL | HBV-Ag | (−) | Hyaline cast | 1–4 | /WF | ||||
| AST | 39 | IU/L | HbA1c | 5.7 | % | HCV-Ab | (−) | NAG | 171.5 | U/l | |
| ALT | 42 | IU/L | CRP | 1.25 | mg/dL | β2MG | 65.2 | µg/L | |||
| ALP | 184 | IU/L | IgG | 994 (870–1,700) | mg/dL | PH | 7.184 | FENa | 0.62 | % | |
| LDH | 467 | IU/L | IgA | 473 (110–410) | mg/dL | HCO3 | 7.7 | mmol/L | Culture | ||
| γ-GTP | 14 | IU/L | IgM | 67 (34–220) | mg/dL | BE | −19.4 | mmol/L | |||
| CK | 572 | IU/L | IgE | 2,589 (3.4–304) | IU/mL | ||||||
| BUN | 182.0 | mg/dL | BNP | 88.5 | Pg/mL | ||||||
| Cr | 7.70 | mg/dL | |||||||||
WBC, white blood cells; Neutro, neutrophils; Lym, lymphocytes; Mono, monocytes; Eosino, eosinophils; Baso, basophils; RBC, red blood cells; Hb, hemoglobin; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; LDH, lactate dehydrogenase; γ-GTP, gamma-guanosine triphosphate; CK, creatine kinase; BUN, blood urea nitrogen; Cr, creatinine; Na, sodium; K, potassium; Cl, chloride; Ca, calcium; IP, inorganic phosphate; TP, total protein; Alb, albumin; TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; BS, blood sugar; HbA1c, glycated hemoglobin; CRP, C-reactive protein; IgG, immunoglobulin G; IgA, immunoglobulin A; IgM, immunoglobulin M; IgE, immunoglobulin E; BNP, brain natriuretic peptide; CH50, total complement; TSH, thyroid-stimulating hormone; fT3, free triiodothyronine; fT4, free thyroxine; MPO, myeloperoxidase; ANCA, antineutrophil cytoplasmic antibodies; PR3, proteinase 3; GBM Ab, glomerular basement membrane antibody; ANA, antinuclear antibody; HBV-Ag, hepatitis B virus antigen; HCV-Ab, hepatitis C virus antibody; HCO3, bicarbonate; BE, base excess; NAG, N-acetyl glucosaminidase; β2MG, β2 microglobulin; FENa, fractional excretion of sodium.
Fig. 1a Light microscopy showing minor glomerular abnormalities and very mild segmental mesangial proliferation (arrowheads). Moderate hyalinosis of the artery is also seen (arrow). Periodic acid Schiff staining with original magnification ×400. b Faint and segmental positive immunostaining of IgA, IgG, and C3 in the mesangial area. c Electron microscopic examination revealing diffuse effacement of podocyte foot processes. Electron-dense deposits are seen in the paramesangial areas (arrowheads). Electron microscopy, original magnification ×2,500.
Fig. 2Anasarca and cardiomegaly were aggravated for several days. Aggressive fluid removal by hemodialysis was effective for improving renal function. After the discontinuation of hemodialysis, prednisolone treatment was started, and complete remission of NS was achieved. BW, body weight; Cr, creatinine; HD, hemodialysis; mPSL, methylprednisolone; PSL, prednisolone; Up, urinary protein; UV, urinary volume.